Annual Total Long Term Liabilities
$38.34 M
+$11.12 M+40.87%
December 31, 2023
Summary
- As of February 8, 2025, SPRO annual total long term liabilities is $38.34 million, with the most recent change of +$11.12 million (+40.87%) on December 31, 2023.
- During the last 3 years, SPRO annual total long term liabilities has risen by +$31.27 million (+442.49%).
- SPRO annual total long term liabilities is now -40.19% below its all-time high of $64.11 million, reached on December 31, 2021.
Performance
SPRO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$20.56 M
-$3.19 M-13.43%
September 30, 2024
Summary
- As of February 8, 2025, SPRO quarterly total long term liabilities is $20.56 million, with the most recent change of -$3.19 million (-13.43%) on September 30, 2024.
- Over the past year, SPRO quarterly long term liabilities has dropped by -$17.79 million (-46.38%).
- SPRO quarterly long term liabilities is now -67.93% below its all-time high of $64.11 million, reached on December 31, 2021.
Performance
SPRO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SPRO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.9% | -46.4% |
| 3 y3 years | +442.5% | -46.4% |
| 5 y5 years | +4503.0% | -46.4% |
SPRO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.2% | +40.9% | -67.9% | +52.5% |
| 5 y | 5-year | -40.2% | +688.0% | -67.9% | +335.0% |
| alltime | all time | -40.2% | >+9999.0% | -67.9% | +6989.0% |
Spero Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.56 M(-13.4%) |
| Jun 2024 | - | $23.75 M(-19.9%) |
| Mar 2024 | - | $29.63 M(-22.7%) |
| Dec 2023 | $38.34 M(+40.9%) | $38.34 M(+37.3%) |
| Sep 2023 | - | $27.93 M(+4.3%) |
| Jun 2023 | - | $26.78 M(+8.3%) |
| Mar 2023 | - | $24.72 M(-9.2%) |
| Dec 2022 | $27.22 M(-57.5%) | $27.22 M(+72.6%) |
| Sep 2022 | - | $15.77 M(+17.0%) |
| Jun 2022 | - | $13.48 M(-4.8%) |
| Mar 2022 | - | $14.16 M(-77.9%) |
| Dec 2021 | $64.11 M(+807.1%) | $64.11 M(+312.6%) |
| Sep 2021 | - | $15.54 M(-5.9%) |
| Jun 2021 | - | $16.52 M(+141.8%) |
| Mar 2021 | - | $6.83 M(-3.4%) |
| Dec 2020 | $7.07 M | $7.07 M(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $6.69 M(+38.8%) |
| Jun 2020 | - | $4.82 M(+2.0%) |
| Mar 2020 | - | $4.73 M(-2.9%) |
| Dec 2019 | $4.87 M(+484.2%) | $4.87 M(+10.1%) |
| Sep 2019 | - | $4.42 M(-3.3%) |
| Jun 2019 | - | $4.57 M(-2.8%) |
| Mar 2019 | - | $4.70 M(+464.6%) |
| Dec 2018 | $833.00 K(+128.2%) | $833.00 K(+187.2%) |
| Sep 2018 | - | $290.00 K(-10.2%) |
| Jun 2018 | - | $323.00 K(-1.2%) |
| Mar 2018 | - | $327.00 K(-10.4%) |
| Dec 2017 | $365.00 K(-26.0%) | $365.00 K(-8.5%) |
| Sep 2017 | - | $399.00 K(-7.9%) |
| Jun 2017 | - | $433.00 K(-12.2%) |
| Dec 2016 | $493.00 K(-51.3%) | $493.00 K |
| Dec 2015 | $1.01 M | - |
FAQ
- What is Spero Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Spero Therapeutics?
- What is Spero Therapeutics annual total long term liabilities year-on-year change?
- What is Spero Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Spero Therapeutics?
- What is Spero Therapeutics quarterly long term liabilities year-on-year change?
What is Spero Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SPRO is $38.34 M
What is the all time high annual total long term liabilities for Spero Therapeutics?
Spero Therapeutics all-time high annual total long term liabilities is $64.11 M
What is Spero Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SPRO annual total long term liabilities has changed by +$11.12 M (+40.87%)
What is Spero Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SPRO is $20.56 M
What is the all time high quarterly long term liabilities for Spero Therapeutics?
Spero Therapeutics all-time high quarterly total long term liabilities is $64.11 M
What is Spero Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SPRO quarterly total long term liabilities has changed by -$17.79 M (-46.38%)